Review: taking Cetirizine hydrochloride and Delsym together


Summary

Drug interactions are reported among people who take Cetirizine hydrochloride and Delsym together. This review analyzes the effectiveness and drug interactions between Cetirizine hydrochloride and Delsym. It is created by eHealthMe based on reports of 60 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Cetirizine hydrochloride and Delsym >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Cetirizine Hydrochloride

Cetirizine hydrochloride has active ingredients of cetirizine hydrochloride. It is often used in hypersensitivity. (latest outcomes from Cetirizine hydrochloride 3,051 users)

Delsym

Delsym has active ingredients of dextromethorphan polistirex. It is often used in cough. (latest outcomes from Delsym 1,023 users)

On Aug, 30, 2016

60 people who take Cetirizine Hydrochloride, Delsym are studied.


Number of reports submitted per year:

Cetirizine hydrochloride and Delsym drug interactions.

Drug effectiveness over time:

Cetirizine Hydrochloride:
  • < 1 month: 42.0% - (3 of 7 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Delsym:
  • < 1 month: 0.0% - (0 of 7 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Cetirizine Hydrochloride:
  • female: 50.0% - (3 of 6 people)
  • male: 40.0% - (2 of 5 people)
Delsym:
  • female: 20.0% - (1 of 5 people)
  • male: 0.0% - (0 of 4 people)

Drug effectiveness by age:

Cetirizine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 25.0% - (2 of 8 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Delsym:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 14.0% - (1 of 7 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • biopsy lymph gland abnormal
  • blood chloride decreased
  • blood creatinine decreased
  • cough aggravated
  • dyspnoea
  • hives
  • laryngitis
  • muscle spasms
  • unresponsive to stimuli
  • accidental overdose
1 - 2 years:
  • cough aggravated
  • hives
  • laryngitis
not specified:
  • muscle spasms
  • pain in extremity
  • accidental overdose
  • muscle spasticity
  • dyspnoea
  • feeling hot
  • body temperature increased
  • abdominal pain
  • abdominal pain upper
  • cholecystitis chronic

Most common drug interactions by gender *:

female:
  • muscle spasms
  • pain in extremity
  • accidental overdose
  • muscle spasticity
  • dyspnoea
  • feeling hot
  • unresponsive to stimuli
  • body temperature increased
  • cough aggravated
  • hives
male:
  • accidental overdose
  • muscle spasms
  • pain in extremity
  • angina unstable
  • lipase increased
  • pancreatitis acute
  • pneumonia
  • productive cough
  • respiratory tract infection
  • sinusitis

Most common drug interactions by age *:

2-9:
  • muscle spasms
  • accidental overdose
  • pain in extremity
  • muscle spasticity
  • dyspnoea
  • feeling hot
  • unresponsive to stimuli
  • biopsy lymph gland abnormal
  • blood chloride decreased
  • blood creatinine decreased
10-19:
  • conversion disorder
  • malaise
  • tremor
  • body temperature increased
  • cough
20-29:
  • cough aggravated
  • hives
  • laryngitis
  • cholecystitis chronic
  • injury
30-39:
  • abdominal pain
  • abdominal pain upper
  • cholecystitis chronic
  • depression
  • gallbladder cholesterolosis
  • generalised anxiety disorder
  • hepatic steatosis
  • obsessive-compulsive disorder
  • white blood cell count increased
40-49:
  • drug ineffective
  • asthenia
  • confusion
  • cough
  • pneumonia
  • pyrexia
50-59:
  • cough
  • fatigue
  • influenza like illness
  • nausea
  • oesophageal reflux
60+:
  • angina unstable
  • anxiety
  • atrial fibrillation
  • blood cholesterol increased
  • bradycardia
  • bronchitis
  • muscle spasms
  • pain in extremity
  • accidental overdose
  • confusional state

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Cetirizine hydrochloride and Delsym?

Can you answer these questions?

More questions for: Cetirizine hydrochloride, Delsym

You may be interested in these reviews

More reviews for: Cetirizine hydrochloride, Delsym

On eHealthMe, Cetirizine hydrochloride (cetirizine hydrochloride) is often used to treat hypersensitivity. Delsym (dextromethorphan polistirex) is often used to treat cough. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.